Brief: Coloplast Keeps Full Year Guidance
Aug 20 (Reuters) - Coloplast A/S COLOb.CO :
* FY 2023/24 GUIDANCE UNCHANGED
* GOOD MOMENTUM IN CHRONIC CARE WITH GROWTH ACROSS OUR
REGIONS AS
WELL AS A STRONG PERFORMANCE IN Q3 FROM OUR ADVANCED WOUND CARE
BUSINESS
* ATOS MEDICAL AND KERECIS, DELIVERED ANOTHER SOLID QUARTER
WITH
DOUBLE-DIGIT GROWTH
Source text for Eikon: ID:nGNE2kWPKX
Further company coverage: COLOb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Coloplast A/S
See all newsMorgan Stanley sees selective medtech opportunities on growth recovery
Brief: Coloplast’s Inflatable Penile Prosthesis Approved By FDA
Denmark's Coloplast Q2 organic revenue rises 6% on urology momentum
Brief: Coloplast Books DKK 3 Bln Impairment In H1
Brief: Coloplast Receives Innovative Technology Contract From Vizient For Biatain® Silicone Fit